Palatin Announces Presentation at the Eyecelerator@AAO 2022 Conference
/PRNewswire/ -- Palatin Technologies, Inc. ("Palatin") (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules...
United States Paul Kayne Palatin Progressing Development Programs In Retinal Sciences At Palatin Prnewswire Palatin Technologies Inc American Academy Of Ophthalmology
Source: prnewswire.com